AU3130493A - Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding - Google Patents

Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding

Info

Publication number
AU3130493A
AU3130493A AU31304/93A AU3130493A AU3130493A AU 3130493 A AU3130493 A AU 3130493A AU 31304/93 A AU31304/93 A AU 31304/93A AU 3130493 A AU3130493 A AU 3130493A AU 3130493 A AU3130493 A AU 3130493A
Authority
AU
Australia
Prior art keywords
therapeutic
expression
receptor binding
methods based
diagnostic methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31304/93A
Other languages
English (en)
Inventor
C. Anthony Altar
Peter Distefano
Carolyn Hyman
Nancy Ip
Ronald Lindsay
Roseann Ventimiglia
Stanley Wiegand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneron Pharmaceuticals Inc
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Publication of AU3130493A publication Critical patent/AU3130493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31304/93A 1991-11-12 1992-11-12 Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding Abandoned AU3130493A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79085791A 1991-11-12 1991-11-12
US790857 1991-11-12

Publications (1)

Publication Number Publication Date
AU3130493A true AU3130493A (en) 1993-06-15

Family

ID=25151941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31304/93A Abandoned AU3130493A (en) 1991-11-12 1992-11-12 Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding

Country Status (6)

Country Link
CN (1) CN1073264A (fr)
AU (1) AU3130493A (fr)
IL (1) IL103730A0 (fr)
PT (1) PT101051A (fr)
WO (1) WO1993009798A1 (fr)
ZA (1) ZA928730B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269075A1 (fr) * 1996-10-16 1998-04-23 Regeneron Pharmaceuticals, Inc. Procede d'amelioration de l'administration de facteurs de croissance
WO1998021245A1 (fr) * 1996-11-08 1998-05-22 Roche Diagnostics Gmbh Anticorps a haute affinite diriges contre le bdnf humain, procedes permettant sa production, et son utilisation
EP1173768B1 (fr) * 1999-05-03 2006-10-25 Evotec AG Procédés permettant le diagnostic, la prévison, l'évaluation de la progression ou du traitement de la dépression basés sur des quantités élevées de neurotrophin dans le liquide cérébrospinal.
EP1050758A1 (fr) * 1999-05-03 2000-11-08 Evotec BioSystems AG Méthodes de diagnostic ou de traitement de maladies neuropsychiatriques basées sur des taux accrus de la neurotrophine 3 dans la fluide cérébrospinale
US6548062B2 (en) * 2000-02-29 2003-04-15 Cephalon, Inc. Method of treating cancer with anti-neurotrophin agents
CN110812532A (zh) * 2019-08-20 2020-02-21 中山大学 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868107A (en) * 1986-11-18 1989-09-19 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting antibodies against neuropeptides and drugs in human body fluid

Also Published As

Publication number Publication date
IL103730A0 (en) 1993-04-04
WO1993009798A1 (fr) 1993-05-27
ZA928730B (en) 1993-05-10
PT101051A (pt) 1994-02-28
CN1073264A (zh) 1993-06-16

Similar Documents

Publication Publication Date Title
AU5588896A (en) Implantable medical device
AU5903196A (en) Implantable osteosynthesis device
AU4853796A (en) Self-retracting medical needle apparatus and methods
AU3897595A (en) Skin examination device
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU2669197A (en) Medical implantable ceramic device
AU4172597A (en) Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
AU4114993A (en) Biocompatible, therapeutic, implantable device
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU1531292A (en) Liquid-impermeable tissue
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
AU2312392A (en) Skin treatment device
HK1014938A1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
AU3130493A (en) Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding
AU1425095A (en) Infrared treatment device for physical examination and treatment
GB9514816D0 (en) Substances and their medical use
AU8019494A (en) Human endothelin-bombesin receptor
AU2444692A (en) Human substance p receptor
AU7335594A (en) Dental diagnostic and instructional apparatus
AU3628697A (en) Lipid-binding proteins and their therapeutic and diagnostic use
EP0587806A4 (fr) Procedes therapeutiques et diagnostiques basees sur l'expression de neurotrophine-4.
AU3300397A (en) Cyclin-c variants, and diagnostic and therapeutic uses thereof
AU8230491A (en) Medical diagnoser device and use
AUPN691195A0 (en) Therapeutic and diagnostic compositions - B